Management of Post-Operative Nausea and Difficulty Swallowing in an Elderly Female
Immediate Post-Operative Nausea Management
For post-operative nausea in this elderly female patient, use ondansetron 4 mg IV as first-line therapy, avoiding droperidol and antihistamines due to her age-related increased risk of delirium and sedation. 1
Specific Drug Selection for Elderly Patients
Ondansetron is the preferred antiemetic because it probably reduces sedation (RR 0.87,95% CI 0.79 to 0.96) compared to placebo, which is critical in elderly patients at high risk for postoperative delirium 2
Avoid the following medications specifically in elderly patients: 1
- Hyoscine (scopolamine) patches should be avoided in the elderly despite effectiveness for PONV 1
- Antihistamines including cyclizine precipitate delirium and should be avoided 1
- Benzodiazepines, atropine, and sedative hypnotics increase delirium risk 1
- Long-acting anxiolytic drugs should be avoided, particularly in the elderly 1
Dexamethasone 4-5 mg IV can be added as second-line therapy if ondansetron alone is insufficient, as this lower dose provides equivalent antiemetic efficacy to 8-10 mg doses while minimizing hyperglycemia risk 3, 1
Multimodal Approach Specific to Elderly
Minimize opioid use through multimodal analgesia, as opioids are a major PONV trigger and should be used cautiously in elderly patients with poor renal or respiratory function 1, 4
Ensure adequate hydration with intravenous fluids, as hypovolemia and hypotension are modifiable PONV risk factors 4
If breakthrough nausea occurs despite ondansetron prophylaxis, use metoclopramide 10 mg IV (a different drug class) rather than repeating ondansetron 3
Difficulty Swallowing (Dysphagia) Management
Dysphagia in the immediate post-operative period requires urgent assessment for surgical complications, particularly airway compromise from hematoma, before attributing symptoms to simple nerve irritation or medication side effects. 1, 3
Immediate Assessment Protocol
Perform flexible laryngoscopy by an experienced operator to assess vocal cord function and identify the specific cause of hoarseness or dysphagia 3
Watch for signs of airway compromise including stridor, difficulty breathing, or rapidly expanding neck swelling that may indicate hematoma rather than simple nerve injury 3
Increase observation frequency after any intervention, particularly if dexamethasone has been administered 3
Management Based on Cause
If dysphagia is related to surgical manipulation or nerve irritation:
If related to PONV-induced vomiting:
Nutritional Support
Continue or institute early enteral nutrition to improve wound healing and recovery, with supplementation as required 1
Facilitate enteral nutrition by delivering age-appropriate anesthesia, appropriate fluid therapy, avoiding reliance on postoperative opioid analgesia, and preventing postoperative nausea 1
Consume ≥1.5 L liquids per day to prevent dehydration, which can worsen dysphagia 1
Critical Pitfalls to Avoid
Do not use droperidol as first-line therapy in elderly patients despite its effectiveness (RR 0.61 for vomiting prevention), as it may cause excessive sedation and increase delirium risk 2, 1
Do not attribute dysphagia solely to medication side effects without ruling out surgical complications such as hematoma, nerve injury, or airway compromise 3
Do not use the same antiemetic class for rescue therapy that was used for prophylaxis, as this reduces effectiveness 3
Do not delay laryngoscopy if dysphagia persists beyond expected recovery time or worsens, as transient paralysis from local anesthetics typically resolves within 1-3 days 3
Dose-Specific Recommendations
Ondansetron: Use 4 mg IV initially, as recommended and high doses (4-8 mg) show clinically important benefit for vomiting prevention, while low doses do not 2
If oral therapy is needed post-operatively, ondansetron 8 mg orally twice daily can be used, though IV ondansetron is more effective for immediate post-operative nausea 5
Dexamethasone: Use 4-5 mg IV rather than 8-10 mg to minimize hyperglycemia risk while maintaining antiemetic efficacy 3, 1